Lyell Immunopharma, Inc. (LYEL)

Lyell Immunopharma Statistics

Total Valuation

LYEL has a market cap or net worth of $153.52 million. The enterprise value is -$164.80 million.

Market Cap	153.52M
Enterprise Value	-164.80M

Important Dates

The last earnings date was Tuesday, March 11, 2025, after market close.

Earnings Date	Mar 11, 2025
Ex-Dividend Date	n/a

Share Statistics

LYEL has 295.23 million shares outstanding. The number of shares has increased by 4.18% in one year.

Current Share Class	295.23M
Shares Outstanding	295.23M
Shares Change (YoY)	+4.18%
Shares Change (QoQ)	+9.22%
Owned by Insiders (%)	3.29%
Owned by Institutions (%)	47.82%
Float	201.56M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2,619.31
Forward PS	n/a
PB Ratio	0.42
P/TBV Ratio	0.42
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.06, with a Debt / Equity ratio of 0.15.

Current Ratio	7.06
Quick Ratio	6.89
Debt / Equity	0.15
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -66.10% and return on invested capital (ROIC) is -23.59%.

Return on Equity (ROE)	-66.10%
Return on Assets (ROA)	-22.05%
Return on Invested Capital (ROIC)	-23.59%
Return on Capital Employed (ROCE)	-50.09%
Revenue Per Employee	$203
Profits Per Employee	-$1.14M
Employee Count	300
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -73.47% in the last 52 weeks. The beta is -0.42, so LYEL's price volatility has been lower than the market average.

Beta (5Y)	-0.42
52-Week Price Change	-73.47%
50-Day Moving Average	0.61
200-Day Moving Average	1.10
Relative Strength Index (RSI)	43.71
Average Volume (20 Days)	879,178

Short Selling Information

The latest short interest is 5.98 million, so 2.02% of the outstanding shares have been sold short.

Short Interest	5.98M
Short Previous Month	8.09M
Short % of Shares Out	2.02%
Short % of Float	2.97%
Short Ratio (days to cover)	6.41

Income Statement

In the last 12 months, LYEL had revenue of $61,000 and -$342.99 million in losses. Loss per share was -$1.31.

Revenue	61,000
Gross Profit	61,000
Operating Income	-218.93M
Pretax Income	-210.26M
Net Income	-342.99M
EBITDA	-199.30M
EBIT	-218.93M
Loss Per Share	-$1.31

Balance Sheet

The company has $370.53 million in cash and $58.97 million in debt, giving a net cash position of $324.57 million or $1.10 per share.

Cash & Cash Equivalents	370.53M
Total Debt	58.97M
Net Cash	324.57M
Net Cash Per Share	$1.10
Equity (Book Value)	382.82M
Book Value Per Share	1.30
Working Capital	325.81M

Cash Flow

In the last 12 months, operating cash flow was -$162.39 million and capital expenditures -$464,000, giving a free cash flow of -$162.86 million.

Operating Cash Flow	-162.39M
Capital Expenditures	-464,000
Free Cash Flow	-162.86M
FCF Per Share	-$0.55

Margins

Gross Margin	100.00%
Operating Margin	-358,906.56%
Pretax Margin	-562,285.25%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

LYEL does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.18%
Shareholder Yield	n/a
Earnings Yield	-214.67%
FCF Yield	-101.93%

Analyst Forecast

The average price target for LYEL is $1.00, which is 92.31% higher than the current price. The consensus rating is "Sell".

Price Target	$1.00
Price Target Difference	92.31%
Analyst Consensus	Sell
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LYEL has an Altman Z-Score of -2.03 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-2.03
Piotroski F-Score	1